Related Experiment Video
Updated: Aug 23, 2025
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Implication of Nanoparticles to Combat Chronic Liver and Kidney Diseases: Progress and Perspectives
Mariam Hashim1, Huma Mujahid2, Samina Hassan3
1Department of Biotechnology, Kinnaird College for Women, Jail Road, Lahore 54000, Pakistan.
Abstract:
Liver and kidney diseases are the most frequently encountered problems around the globe. Damage to the liver and kidney may occur as a result of exposure to various drugs, chemicals, toxins, and pathogens, leading to severe disease conditions such as cirrhosis, fibrosis, hepatitis, acute kidney injury, and liver and renal failure. In this regard, the use of nanoparticles (NPs) such as silver nanoparticles (AgNPs), gold nanoparticles (AuNPs), and zinc oxide nanoparticles (ZnONPs) has emerged as a rapidly developing field of study in terms of safe delivery of various medications to target organs with minimal side effects. Due to their physical characteristics, NPs have inherent pharmacological effects, and an accidental buildup can have a significant impact on the structure and function of the liver and kidney. By suppressing the expression of the proinflammatory cytokines iNOS and COX-2, NPs are known to possess anti-inflammatory effects. Additionally, NPs have demonstrated their ability to operate as an antioxidant, squelching the generation of ROS caused by substances that cause oxidative stress. Finally, because of their pro-oxidant properties, they are also known to increase the level of ROS, which causes malignant liver and kidney cells to undergo apoptosis. As a result, NPs can be regarded as a double-edged sword whose inherent therapeutic benefits can be refined as we work to comprehend them in terms of their toxicity.
Insights
Nanoparticles (NPs) show promise for treating liver and kidney diseases by delivering medication and offering anti-inflammatory and antioxidant effects. However, their dual nature requires careful study to manage potential toxicity.
Area of Science:
- Nanomedicine
- Toxicology
- Biomaterials
Background:
- Liver and kidney diseases are global health issues caused by toxins, pathogens, and drugs.
- These conditions can lead to severe outcomes like cirrhosis, fibrosis, hepatitis, and organ failure.
- Nanoparticles (NPs) are being explored for targeted drug delivery to minimize side effects.
Purpose of the Study:
- To investigate the dual role of nanoparticles (NPs) in liver and kidney health.
- To explore the therapeutic potential and inherent risks associated with NP accumulation.
- To understand how NPs interact with inflammatory and oxidative stress pathways in target organs.
Main Methods:
- Review of existing literature on nanoparticle interactions with liver and kidney tissues.
- Analysis of NP mechanisms including anti-inflammatory effects (iNOS, COX-2 suppression) and antioxidant properties (ROS scavenging).
- Examination of NP pro-oxidant effects leading to apoptosis in malignant liver and kidney cells.
Main Results:
- NPs exhibit anti-inflammatory properties by suppressing key pro-inflammatory cytokines.
- NPs can act as antioxidants, mitigating oxidative stress.
- NPs possess pro-oxidant capabilities, inducing apoptosis in cancerous liver and kidney cells.
Conclusions:
- Nanoparticles present a double-edged sword in managing liver and kidney diseases.
- Their therapeutic benefits can be optimized by understanding and controlling their inherent toxicity.
- Further research is crucial to harness NPs safely and effectively for treating hepatic and renal conditions.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:24Chronic Kidney Disease II: Clinical Manifestations